Clinical Trial Update: Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases

View source ↗

Summary

Clinical trial update evaluating the safety of the Sofosbuvir and Daclatasvir combination in hepatitis C patients, including resistant and relapsed cases; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Assiut University | Conditions: HCV | Status: UNKNOWN